Mild electrical brain stimulation did not further improve motor recovery in stroke survivors, according to late-breaking science presented at the American Stroke Association's International Stroke ...

Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).

Analysts said Nevro’s valuation was “inexpensive,” but the spinal cord stimulation business can benefit from Globus’ scale ...

Globus Medical Inc. (NYSE:GMED), a medical device company with a market capitalization of $12 billion and an "GREAT" financial health rating according to InvestingPro, reaffirmed its commitment to ...

Montgomery County's Globus Medical has agreed to acquire a California life sciences company focused on treating chronic pain ...

Dr. Muir is a dual board-certified psychiatrist in both child and general psychiatry, with expertise in managing complex mood disorders. He serves as a Clinical Assistant Professor of Medicine at the ...

A transcutaneous electrical stimulation system (TESS) is effective in reducing both symptoms and esophageal acid exposure ...

NeurAxis has secured medical policy coverage for its IB-Stim technology with Molina Healthcare, expanding access to its treatment for 5.1 million members across multiple states. The coverage marks ...

[Image from Nalu Medical] Nalu Medical announced today ... Carlsbad, California–based Nalu offers FDA-cleared spinal cord stimulation and peripheral nerve stimulation technology.

Alpha-Stim AID cranial electrotherapy stimulation (CES) has evidence of effectiveness in the treatment of anxiety and depression. Purpose: Evaluation of Alpha-Stim AID on anxiety and depression for ...